These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19307354)

  • 21. Oral rifampin for eradication of Staphylococcus aureus carriage from healthy and sick populations: a systematic review of the evidence from comparative trials.
    Falagas ME; Bliziotis IA; Fragoulis KN
    Am J Infect Control; 2007 Mar; 35(2):106-14. PubMed ID: 17327190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Agranulocytosis during therapy with orally administered cloxacillin.
    Westerman EL; Bradshaw MW; Williams TW
    Am J Clin Pathol; 1978 May; 69(5):559-60. PubMed ID: 655134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of Tedizolid in Methicillin-Resistant Staphylococcus aureus Experimental Foreign Body-Associated Osteomyelitis.
    Park KH; Greenwood-Quaintance KE; Mandrekar J; Patel R
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6568-6572. PubMed ID: 27550347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Right endocarditis caused by Staphylococcus aureus in parenteral drug addicts: evaluation of a combined therapeutic scheme for 2 weeks versus conventional treatment].
    Espinosa FJ; Valdés M; Martín-Luengo F; Arribas JP; Albaladejo J; Pérez-Gracia A; García-Henarejos JA; Martínez-Madrid O; García-Alberola A
    Enferm Infecc Microbiol Clin; 1993 May; 11(5):235-40. PubMed ID: 8324018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A controlled trial of cloxacillin and tetracycline in chronic staphylococcal osteomyelitis in Ugandan children.
    Hubbard MJ; Ndawula AL
    East Afr Med J; 1973 Aug; 50(8):480-5. PubMed ID: 4586657
    [No Abstract]   [Full Text] [Related]  

  • 26. Successful management of methicillin-resistant Staphylococcus aureus orbital cellulitis after blepharoplasty.
    Juthani V; Zoumalan CI; Lisman RD; Rizk SS
    Plast Reconstr Surg; 2010 Dec; 126(6):305e-307e. PubMed ID: 21124103
    [No Abstract]   [Full Text] [Related]  

  • 27. Factors involved in the antibiotic treatment of cerebrospinal fluid shunt infections.
    Bayston R; Rickwood AM
    Z Kinderchir; 1981 Dec; 34(4):339-45. PubMed ID: 6977247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental chronic staphylococcal osteomyelitis in rabbits: treatment with rifampin alone and in combination with other antimicrobial agents.
    Norden CW
    Rev Infect Dis; 1983; 5 Suppl 3():S491-4. PubMed ID: 6635438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus.
    Murillo O; Doménech A; Garcia A; Tubau F; Cabellos C; Gudiol F; Ariza J
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4011-7. PubMed ID: 17015630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative activities of vancomycin, tigecycline and rifampin in a rat model of methicillin-resistant Staphylococcus aureus osteomyelitis.
    Vergidis P; Schmidt-Malan SM; Mandrekar JN; Steckelberg JM; Patel R
    J Infect; 2015 Jun; 70(6):609-15. PubMed ID: 25576292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy of experimental staphylococcal mastitis in the mouse with cloxacillin and rifampicin, alone and in combination.
    Craven N; Anderson JC
    Res Vet Sci; 1981 Nov; 31(3):295-300. PubMed ID: 6919178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcome.
    Walsh TJ; Standiford HC; Reboli AC; John JF; Mulligan ME; Ribner BS; Montgomerie JZ; Goetz MB; Mayhall CG; Rimland D
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1334-42. PubMed ID: 8328783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group.
    Zimmerli W; Widmer AF; Blatter M; Frei R; Ochsner PE
    JAMA; 1998 May; 279(19):1537-41. PubMed ID: 9605897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin.
    Henry NK; Rouse MS; Whitesell AL; McConnell ME; Wilson WR
    Am J Med; 1987 Apr; 82(4A):73-5. PubMed ID: 3578332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacterial osteomyelitis: microbiological, clinical, therapeutic, and evolutive characteristics of 344 episodes.
    García Del Pozo E; Collazos J; Cartón JA; Camporro D; Asensi V
    Rev Esp Quimioter; 2018 Jun; 31(3):217-225. PubMed ID: 29756429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel Use of Rifabutin and Rifapentine to Treat Methicillin-Resistant Staphylococcus aureus in a Rat Model of Foreign Body Osteomyelitis.
    Karau MJ; Schmidt-Malan SM; Albano M; Mandrekar JN; Rivera CG; Osmon DR; Oravec CP; Berry DJ; Abdel MP; Patel R
    J Infect Dis; 2020 Oct; 222(9):1498-1504. PubMed ID: 32914837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerance of rifampicin-linezolid compared with rifampicin-cotrimoxazole combinations in prolonged oral therapy for bone and joint infections.
    Nguyen S; Pasquet A; Legout L; Beltrand E; Dubreuil L; Migaud H; Yazdanpanah Y; Senneville E
    Clin Microbiol Infect; 2009 Dec; 15(12):1163-9. PubMed ID: 19438638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of experimental chronic osteomyelitis due to staphylococcus aureus with vancomycin and rifampin.
    Norden CW; Shaffer M
    J Infect Dis; 1983 Feb; 147(2):352-7. PubMed ID: 6827150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of Tedizolid in Methicillin-Resistant Staphylococcus epidermidis Experimental Foreign Body-Associated Osteomyelitis.
    Park KH; Greenwood-Quaintance KE; Schuetz AN; Mandrekar JN; Patel R
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rifampin-Based Combination Therapy Is Active in Foreign-Body Osteomyelitis after Prior Rifampin Monotherapy.
    Brinkman CL; Schmidt-Malan SM; Mandrekar JN; Patel R
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.